These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Results of bleeding prevention with fibrinolysis inhibitors in intrauterine contraception]. Tauber PF; Werling E; Klöppel A; Ludwig H Arch Gynecol; 1979 Jul; 228(1-4):637-8. PubMed ID: 485529 [No Abstract] [Full Text] [Related]
43. High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage. Glick R; Green D; Ts'ao C; Witt WA; Yu AT; Raimondi AJ Neurosurgery; 1981 Oct; 9(4):398-401. PubMed ID: 7301085 [TBL] [Abstract][Full Text] [Related]
44. Epsilon-aminocaproic acid therapy in cyclophosphamide-induced bladder hemorrhage. A case report. Covey WG Conn Med; 1971 Mar; 35(3):160-3. PubMed ID: 5581530 [No Abstract] [Full Text] [Related]
48. Palliative use of aminocaproic acid to control upper gastrointestinal bleeding. Roberts SB; Coyne PJ; Smith TJ; Lyckholm LJ J Pain Symptom Manage; 2010 Sep; 40(3):e1-3. PubMed ID: 20678887 [No Abstract] [Full Text] [Related]
49. [The use of epsilon-aminocaproic acid in the treatment of acute pancreatits]. Karavanov AG; Osingolts SL Klin Med (Mosk); 1966 May; 44(5):13-5. PubMed ID: 4865586 [No Abstract] [Full Text] [Related]
50. [The treatment of psoriatic arthropathy with a combination of mefenamic and aminocaproic acids]. Kuliev NA Vestn Dermatol Venerol; 1989; (5):43-7. PubMed ID: 2773581 [TBL] [Abstract][Full Text] [Related]
51. Myopathy due to epsilon amino-caproic acid. Kennard C; Swash M; Henson RA Muscle Nerve; 1980; 3(3):202-6. PubMed ID: 6990256 [TBL] [Abstract][Full Text] [Related]
52. Circulating antibodies in factor VIII deficiency hemophilia: report of case. Hanna JD ASDC J Dent Child; 1979; 46(3):259. PubMed ID: 285955 [No Abstract] [Full Text] [Related]
53. [Epsylon-aminocaproic acid in the treatment of severe and dominating hyperfibrinolysis in a premature infant]. Schmidt B; Pringsheim W; Künzer W Helv Paediatr Acta; 1980 Jul; 35(3):273-9. PubMed ID: 6773909 [TBL] [Abstract][Full Text] [Related]
55. Acute delirious state after epsilon-amino caproic acid administration. Wysenbeek AJ; Sella A; Blum I; Yeshurun D Clin Toxicol; 1979; 14(1):93-5. PubMed ID: 436386 [TBL] [Abstract][Full Text] [Related]
56. Potential hazards of antifibrinolytic treatment in subarachnoid haemorrhage. Levati A; Minella C; Farina ML; D'Angelo V Thromb Haemost; 1980 Dec; 44(3):170. PubMed ID: 7466744 [No Abstract] [Full Text] [Related]
57. [Apropos of the use of epsilon-aminocaproic acid in urology]. Rouffilange F; Picard P; Radiguet de la Bastaie P Hemostase; 1965 Dec; 5(4):405-9. PubMed ID: 5880351 [No Abstract] [Full Text] [Related]
58. New anti-hemorrhagic agent, epsilon aminocaproic acid for control of hemorrhage after transurethral prostatic resection: a control study. Warren JW; Stanley KE J Kans Med Soc; 1969 Apr; 70(4):173-6. PubMed ID: 5815183 [No Abstract] [Full Text] [Related]
59. The coagulation disorder in promyelocytic leukemia. Straub PW; Frick PG Helv Med Acta; 1967 Dec; 34(1):44-53. PubMed ID: 5242897 [No Abstract] [Full Text] [Related]
60. Epsilon-amino-caproic acid in the treatment of Osler's hereditary angioneurotic edema. Fernández M; Diéguez I; Neffen H; Oehling A Allergol Immunopathol (Madr); 1983; 11(1):19-23. PubMed ID: 6858804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]